Warfarin vs. Asprin in Reduced Ejection Fraction
Warfarin vs. Asprin in Reduced Ejection Fraction
Warfarin vs. Asprin in Reduced Ejection Fraction
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Basel<strong>in</strong>e F<strong>in</strong>d<strong>in</strong>gs<br />
<strong>Warfar<strong>in</strong></strong><br />
(N=1142)<br />
Aspir<strong>in</strong><br />
(N=1163)<br />
Age 61 ± 11.6 yrs 61 ± 11.1 yrs<br />
Male sex (%) 904 (79.3 %) 936 (80.7 %)<br />
Prior stroke/ TIA (% ) 155 (13.6 %) 139 (12.0 %)<br />
NYHA Classification (%)<br />
I 150 (13.2 %) 165 (14.3 %)<br />
II 621 (54.6 %) 646 (56 %)<br />
III 351 (30.9 %) 329 (28.5 %)<br />
IV 15 (1.3 %) 13 (1.1 %)<br />
<strong>Ejection</strong> <strong>Fraction</strong> 25 ± 7.5 % 25 ± 7.5 %
Change language